myAACR
Donate Today
Skip to Content

Progress Against Cancer

Home Patients, Caregivers, and Advocates Progress Against Cancer Research Page 2

Recent Progress: FDA Approvals

Immunotherapy for Biliary Tract Cancers 

Immunotherapy for Biliary Tract Cancers 

The FDA has approved the immune checkpoint inhibitor pembrolizumab for certain advanced cancers of the biliary tract.  The U.S. Food and Drug Administration (FDA) has approved pembrolizumab (Keytruda), in combination with gemcitabine (Gemzar) and...